AR103632A2 - BENCIMIDAZOL DERIVATIVES - Google Patents

BENCIMIDAZOL DERIVATIVES

Info

Publication number
AR103632A2
AR103632A2 ARP160100340A ARP160100340A AR103632A2 AR 103632 A2 AR103632 A2 AR 103632A2 AR P160100340 A ARP160100340 A AR P160100340A AR P160100340 A ARP160100340 A AR P160100340A AR 103632 A2 AR103632 A2 AR 103632A2
Authority
AR
Argentina
Prior art keywords
alkyl
hydrogen
membered heterocyclyl
independently
nr16r17
Prior art date
Application number
ARP160100340A
Other languages
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AR103632A2 publication Critical patent/AR103632A2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Reivindicación 1: Un compuesto de fórmula (1), en la que: cada R¹ es independientemente halo, alquilo C₁₋₆, alcoxi C₁₋₆, -CF₃, -CN, o -NR¹⁶R¹⁷; R² es hidrógeno o alquilo C₁₋₆; R³B es hidrógeno, alquilo C₁₋₆, -(CH₂)ₜarilo C₆₋₁₂, o -(CH₂)ₜcarbociclilo C₃₋₁₂; R⁴ es hidrógeno o alquilo C₁₋₆; R¹⁰ es -(CH₂)ₜarilo C₆₋₁₂ o -(CH₂)ₜ(heterociclilo de 4 a 14 miembros), en los que cada uno de dichos arilo C₆₋₁₂ y (heterociclilo de 4 a 14 miembros) está opcionalmente sustituido con de 1 a 5 sustituyentes cada uno de los cuales se selecciona independientemente de -alquil C₁₋₆, -CN, halo, -CF₃, -OCF₃, -NR¹⁶R¹⁷, alcoxi C₁₋₆, -NO₂, -(CH₂)ₜarilo C₆₋₁₂, -C(O)alquilo C₁₋₆, -C(O)CF₃, azido, (heterociclilo de 4 a 12 miembros), y -S(alquilo C₁₋₆); cada R¹⁶ y R¹⁷ está independientemente seleccionado de hidrógeno y alquilo C₁₋₆; n es 0, 1, 2, 3, ó 4; y cada t es independientemente 0, 1, ó 2; o una sal farmacéuticamente aceptable del mismo.Claim 1: A compound of formula (1), wherein: each R¹ is independently halo, C alquilo alkyl, C₁₋₆ alkoxy, -CF₃, -CN, or -NR¹⁶R¹⁷; R² is hydrogen or C₁₋₆ alkyl; R³B is hydrogen, C₁₋₆ alkyl, - (CH₂) C₆₋₁₂aryl, or - (CH₂) C₃₋₁₂carbocyclyl; R⁴ is hydrogen or C₁₋₆ alkyl; R¹⁰ is - (CH₂) ₜaryl C₆₋₁₂ or - (CH₂) ₜ (4 to 14-membered heterocyclyl), in which each of said C₆₋₁₂ and (4 to 14-membered heterocyclyl) is optionally substituted with 1 to 5 substituents each of which is independently selected from -C₁₋₆ alkyl, -CN, halo, -CF₃, -OCF₃, -NR¹⁶R¹⁷, C₁₋₆ alkoxy, -NO₂, - (CH₂) Ciloaryl, -C (O) C₁₋₆ alkyl, -C (O) CF₃, azido, (4-12 membered heterocyclyl), and -S (C₁₋₆ alkyl); each R¹⁶ and R¹⁷ is independently selected from hydrogen and C₁₋₆ alkyl; n is 0, 1, 2, 3, or 4; and each t is independently 0, 1, or 2; or a pharmaceutically acceptable salt thereof.

ARP160100340A 2007-06-29 2016-02-05 BENCIMIDAZOL DERIVATIVES AR103632A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94728707P 2007-06-29 2007-06-29

Publications (1)

Publication Number Publication Date
AR103632A2 true AR103632A2 (en) 2017-05-24

Family

ID=43038355

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160100340A AR103632A2 (en) 2007-06-29 2016-02-05 BENCIMIDAZOL DERIVATIVES

Country Status (3)

Country Link
AR (1) AR103632A2 (en)
UA (1) UA93313C2 (en)
ZA (1) ZA200908626B (en)

Also Published As

Publication number Publication date
ZA200908626B (en) 2010-08-25
UA93313C2 (en) 2011-01-25

Similar Documents

Publication Publication Date Title
AR105340A2 (en) DERIVATIVES OF QUINAZOLINONA 5-SUBSTITUTE AND COMPOSITIONS THAT UNDERSTAND THEM
AR106942A2 (en) ISOINDOLINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS OF THE SAME
AR112797A1 (en) KRAS G12C INHIBITORS AND METHODS OF USING THEM
AR067346A1 (en) BENCIMIDAZOL DERIVATIVES
AR094537A1 (en) PIRIDIL COMPOUNDS REPLACED WITH USEFUL ALQUILAMIDE AS MODULATORS OF THE ANSWERS OF IL-12, IL-23 AND / OR IFNa
AR081058A1 (en) DERIVATIVES OF ARILMETOXI ISOINDOLINA, COMPOSITIONS THAT INCLUDE THEM AND THEIR USE IN THE TREATMENT OF CANCER.
AR105845A1 (en) BICYCLIC HETEROARIL COMPOUNDS FUSED AS MODULATORS OF THE IRAK4 FUNCTION
EA201000113A1 (en) PYRAZOL COMPOUNDS
AR094452A1 (en) HETEROCYCLIC COMPOUNDS REPLACED WITH AMIDA USEFUL AS MODULATORS OF THE ANSWERS OF IL-12, IL-23 AND / OR INFa
AR101815A1 (en) COMPOUNDS AND COMPOSITIONS AS QUINASA INHIBITORS
EA201590023A1 (en) NEW 4-SUBSTITUTED DERIVATIVES WITH 1,3-DIHYDRO-2H-BENZIMIDAZOLE-2-SHE, SUBSTITUTED WITH BENZIMIDAZOLES, AS ANTI-VIRUS MEANS AGAINST RESPIRATORY SYNCIAL VIRUS
AR085410A1 (en) DERIVATIVES OF PIRAZOL HETEROARIL-SUBSTITUTES, COMPOSITIONS PESTICIDES THAT UNDERSTAND AND THEIR USE IN PEST CONTROL
RS52261B (en) Amidophenoxyindazoles useful as inhibitors of c-met
UY31940A (en) SUBSTITUTED DERIVATIVES OF 4,5- (SUBSTITUTED-PIRIDIN-3-IL) -1-METHYL-1H-INDOL, ITS PHARMACEUTICALLY ACCEPTABLE SALTS, POLYMORPHOS, ROTÁMEROS, PRO-DRUGS, ANANTIOMERS, HYDRATES, SOLVATOS OF THE SAME AND COMPOSITIONS
CY1115262T1 (en) TRPV1 COMPETITORS AND THEIR USES
SV2010003502A (en) NEW FUNGICIDES
CO6160307A2 (en) PIRAZOLINE COMPOUNDS AND THEIR USE AND PHARMACEUTICAL COMPOSITIONS
AR091939A1 (en) 4-METHYL-2,3,5,9,9B-PENTAAZA-CICLOPENTA [A] NAFTALENOS
BR112013025456A2 (en) Curable composition useful for use as lost circulation material in well drilling
ECSP088965A (en) 2-THIOXANTINE DERIVATIVES THAT ACT AS INHIBITORS OF THE MPO
AR094762A1 (en) HEXAHYDROPIRANE COMPOUNDS [3,4-D] [1,3] TIAZIN-2-AMINA REPLACED WITH HETEROARILE
EA201171062A1 (en) ALKILAMIDE COMPOUNDS AND THEIR APPLICATION
AR082696A1 (en) HITEROCICLIC NITROGEN DERIVATIVES OF 1,2,4-OXADIAZOL, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USE OF THE SAME IN THE TREATMENT OF CARDIOVASCULAR AND INFLAMMATORY DISEASES, AMONG OTHER
AR095422A1 (en) SUBSTITUTED PIPERIDINE COMPOUNDS AND THEIR USE AS OREXIN RECEPTORS MODULATORS
EA201170294A1 (en) METHODS OF TREATMENT OF REPERFUSION DAMAGE

Legal Events

Date Code Title Description
FC Refusal